Sun Pharma Advanced Research Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/01/2026 ,inter alia, to consider and approve the proposal for raising funds by the Company through preferential issue of securities, including convertible warrants.